United States: Dr Shilpa Gupta is the Director of Genitourinary Medical Oncology at the Taussig Cancer Institute and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic. She obtained her medical degree from Lady Hardinge Medical College in New Delhi, India, and completed her residency in Internal Medicine at the University of Connecticut Health Center.
Dr Gupta completed fellowships in Haematology-Oncology and Genitourinary Oncology Translational Research at Thomas Jefferson University. She has held faculty positions at the H. Lee Moffitt Cancer Center and Research Institute and the Masonic Cancer Center, University of Minnesota. Her research focuses on novel drug development and understanding biomarkers of response and resistance in bladder cancer. She leads several NCI trials and is Principal Investigator for the Department of Defense Idea Award on immunotherapy biomarkers in bladder cancer.
Dr Gupta is an active member of professional organisations, including ASCO, AUA, AACR, SITC, and BCAN. She serves on key committees, such as the ASCO Annual Scientific Committee for Genitourinary Cancers and the SITC Anti-PD-1/PD-L1 Resistance Task Force.
